Large-scale probiotic manufacturing facility highlighting high-density fermentation, centrifugation, and freeze-drying technologies with production targets.
Home
BASF Increases Prices for...

BASF Increases Prices for Pharmaceutical Excipients and Active Ingredients

30 Aug 2011
Add nutritioninsight as a preferred source on Google
Image

Due to the continued rise in costs for raw materials, energy and labor this price increase has become necessary. All existing contractual obligations will be honored.

Aug 30 2011 --- Effective September 1, 2011, BASF will increase the sales prices globally for all pharmaceutical excipients and generic active pharmaceutical ingredients by 10%.
 
This price increase affects the entire excipients portfolio including all binders, disintegrants, coatings, solubilizers, and solvents. The affected generic active pharmaceutical ingredient (API) portfolio contains products like Ibuprofen, Caffeine, and Pseudoephedrine.
 
Due to the continued rise in costs for raw materials, energy and labor this price increase has become necessary. All existing contractual obligations will be honored.
 

All content and features on this website are copyrighted with all rights reserved. The full details can be found in our privacy statement
Add nutritioninsight as a preferred source on Google
Subscribe to our newsletters
PlatformsFood Ingredients FirstNutrition InsightPackaging InsightsPersonal Care InsightsThe World of Food Ingredients
About usContact usAdvertisingPrivacy statementSitemapArchive
Follow us
linkedinrss_headergoogle_news
Image